Select country change
Shopping cart (0 , 0,00 ) Menu Search

Scientific References

BioVendor collects scientific publications where the use of our immunoassays, recombinant proteins, and monoclonal and polyclonal antibodies is cited.

Filter references:
  • References to KL-6 Human ELISA

    • Choi S, Won YL, Kim D, Yi GY, Park JS, Kim EA. Subclinical interstitial lung damage in workers exposed to indium compounds. Ann Occup Environ Med. 2013;25(1):24. Published 2013 Oct 21. doi:10.1186/2052-4374-25-24
    • Chou CW, Chao HS, Lin FC, Tsai HC, Yuan WH, Chang SC. Clinical Usefulness of HRCT in Assessing the Severity of Pneumocystis jirovecii Pneumonia: A Cross-sectional Study. Medicine (Baltimore). 2015;94(16):e768.
    • Fatkhutdinova LM, Khaliullin TO, Vasil'yeva OL, et al. Fibrosis biomarkers in workers exposed to MWCNTs. Toxicol Appl Pharmacol. 2016;299:125-31.
    • Guo WL, Zhou ZQ, Chen L, et al. Serum KL-6 in pulmonary alveolar proteinosis: China compared historically with Germany and Japan. J Thorac Dis. 2017;9(2):287-295
    • Shu LH, Lu Q, Han LY, Dong GH. SP-D, KL-6, and HTI-56 levels in children with mycoplasma pneumoniae pneumonia. Int J Clin Exp Pathol. 2015;8(9):11185-91. Published 2015 Sep 1.
    • Sugino K, Shimizu H, Nakamura Y, Isshiki T, Matsumoto K, Homma S. Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis. J Thorac Dis. 2018;10(2):899-908.